MX2022000347A - Combinaciones bioenergeticas y metodos de uso del mismo. - Google Patents

Combinaciones bioenergeticas y metodos de uso del mismo.

Info

Publication number
MX2022000347A
MX2022000347A MX2022000347A MX2022000347A MX2022000347A MX 2022000347 A MX2022000347 A MX 2022000347A MX 2022000347 A MX2022000347 A MX 2022000347A MX 2022000347 A MX2022000347 A MX 2022000347A MX 2022000347 A MX2022000347 A MX 2022000347A
Authority
MX
Mexico
Prior art keywords
skin
cooperative
personal care
mitochondrial fragmentation
topical personal
Prior art date
Application number
MX2022000347A
Other languages
English (en)
Inventor
Jose Guillermo Rosa
John Chun-Sing Nip
Sheila Alves Rocha
Chung-Yi Chiang
Original Assignee
Unilever Ip Holdings B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Ip Holdings B V filed Critical Unilever Ip Holdings B V
Publication of MX2022000347A publication Critical patent/MX2022000347A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se exponen composiciones tópicas para el cuidado personal para mejorar la eficiencia energética celular al proteger la piel de la fragmentación mitocondrial que tiene lugar en las células de un individuo envejecido que necesita del mismo. El uso de una composición tópica para el cuidado personal que comprende niacinamida y uno o más agentes cooperantes benéficos para la piel para reducir la fragmentación mitocondrial celular, cuyos agentes cooperantes se seleccionan del grupo que consiste de cloruro de 1-metilnicotinamida, N-acetilmetionina, mezclas de los mismos y derivados de los mismos. El uso de niacinamida y un agente cooperante benéfico para la piel seleccionado de cloruro de 1-metilnicotinamida, Nacetilmetionina, mezclas de los mismos y derivados de los mismos en la fabricación de una composición tópica para el cuidado personal para disminuir o prevenir la fragmentación mitocondrial en las células de la piel y para aumentar la energía celular de la piel.
MX2022000347A 2019-07-12 2020-06-23 Combinaciones bioenergeticas y metodos de uso del mismo. MX2022000347A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19186091 2019-07-12
PCT/EP2020/067469 WO2021008824A1 (en) 2019-07-12 2020-06-23 Bioenergetic combinations and methods of using same

Publications (1)

Publication Number Publication Date
MX2022000347A true MX2022000347A (es) 2022-02-03

Family

ID=67262199

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022000347A MX2022000347A (es) 2019-07-12 2020-06-23 Combinaciones bioenergeticas y metodos de uso del mismo.

Country Status (8)

Country Link
US (1) US20220362127A1 (es)
EP (1) EP3996669A1 (es)
JP (1) JP2022539607A (es)
CN (1) CN114096233A (es)
CA (1) CA3146376A1 (es)
MX (1) MX2022000347A (es)
WO (1) WO2021008824A1 (es)
ZA (1) ZA202109831B (es)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939082A (en) * 1995-11-06 1999-08-17 The Procter & Gamble Company Methods of regulating skin appearance with vitamin B3 compound
PL190755B1 (pl) 1999-01-07 2006-01-31 Pharmena Sp Z Oo Preparat do leczenia i profilaktyki chorób skóry
US6159485A (en) 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
WO2005055947A2 (en) * 2003-12-08 2005-06-23 Yu Ruey J Enlargement of mucocutaneous or cutaneous organs and sites with topical compositions
US20080112968A1 (en) 2006-10-11 2008-05-15 Dermena Nicotinamide compositions for treatment of skin diseases and disorders
WO2008063441A2 (en) * 2006-11-16 2008-05-29 The Procter & Gamble Company Personal care composition
US20080311058A1 (en) 2007-06-18 2008-12-18 Connopco, Inc., D/B/A Unilever Stable high internal phase emulsions and compositions comprising the same
EP2065029B1 (en) * 2007-11-30 2013-04-17 Evonik Goldschmidt GmbH Personal care and cosmetic composition containing tetrapeptides with the motifs GX1X2G, PX1X2P, or PX1X2K
US8425882B2 (en) 2008-04-01 2013-04-23 Conopco, Inc. In-shower and bath compositions
US9676696B2 (en) * 2009-01-29 2017-06-13 The Procter & Gamble Company Regulation of mammalian keratinous tissue using skin and/or hair care actives
MX365558B (es) * 2014-12-30 2019-06-07 Unilever Nv Una composicion aclaradora de la piel que comprende niacinamida e ilomastat.
CA3000880A1 (en) * 2015-10-05 2017-04-13 Unilever Plc A skin lightening composition

Also Published As

Publication number Publication date
JP2022539607A (ja) 2022-09-12
CA3146376A1 (en) 2021-01-21
EP3996669A1 (en) 2022-05-18
US20220362127A1 (en) 2022-11-17
ZA202109831B (en) 2023-10-25
WO2021008824A1 (en) 2021-01-21
CN114096233A (zh) 2022-02-25

Similar Documents

Publication Publication Date Title
PH12020551923A1 (en) Methods and compositions for treating cancer
MX2019011431A (es) Inhibidores de proteina 1 de muerte celular programada (pd-1)/ligando 1 de muerte programada (pd-l1).
ZA201805792B (en) Taurine and aloe synergistic anti-irritant compositions and methods
PH12016502254A1 (en) Keratin treatment formulations and methods
BR112015030972A8 (pt) células sc-beta e composições e métodos para geração das mesmas
PE20170140A1 (es) Metodos para tratar el cancer con inhibidores de tigit y agentes contra el cancer
NI200700064A (es) Nuevas composiciones farmacéuticas que comprenden ácido 4-(4-(3-(4-cloro-3- trifluorometil-fenil)- ureido)-3-fluoro-fenoxi)-piridin-2-carboxílico para el tratamiento de trastornos hiperproliferativos.
BRPI0510925A (pt) métodos e composições para cicatrização de ferida
EP2513343A4 (en) METHODS AND COMPOSITIONS FOR TREATING SKIN INFLAMMATION
WO2013178965A3 (fr) Principes actifs activateurs de la mitophagie des cellules cutanées et utilisation pour améliorer l'état de la peau
MX2018005796A (es) Reduccion de la sensacion de picazon en la piel.
BR112022000120A2 (pt) Projeto e sínteses eficientes de conjugados de lipídeo-fluoresceína para terapia de células car-t
MX2019011933A (es) Composiciones cosmeticas que contienen sistema enzimatico.
MX2022002337A (es) Polipéptidos de tff2 modificados.
MX2021000719A (es) Composicion de microbiota fecal, para su uso en la reduccion de la inflamacion inducida por tratamiento.
BR112018012749A2 (pt) composições para higiene pessoal
MX345695B (es) Heterociclocarbonilaminotiazoles, preparaciones cosmeticas o dermatologicas que contienen los mismos y su uso para el control y la profilaxis de pigmentacion indeseada de la piel.
CY1124899T1 (el) Μια συνεργιστικη συνθεση ως ενας προωθητης αυτοφαγιας
PH12019500345A1 (en) Conjugate of minoxidil and peptide
ZA202109831B (en) Bioenergetic combinations and methods of using same
CY1123360T1 (el) Ενωσεις oi οποιες εχουν αντιοξειδωτικη δραση εναντι των ελευθερων ριζων και αντιφλεγμονωδη δραση, και αντιστοιχες φαρμακευτικες συνθεσεις για τη φροντιδα του δερματος
ZA202110683B (en) Topical compositions and methods of using same against mitochondrial fragmentation
BRPI0802428A2 (pt) uso de óxidos, e, composição para tratamento de superfìcie
EA202092219A1 (ru) Композиции для ухода за кожей и их применение
MX2016009567A (es) Composicion antifungica.